It is our pleasure to announce that BIOCYTOGEN will host the Gene-ius Break Dinner Party in Cambridge, UK, on February 6, 2025! This event will bring biotech researchers and scientists together to exchange ideas, discuss the latest advancements, and connect with industry peers. Join us to explore our latest research findings while enjoying great food!
What is the Gene-ius Break?
The Gene-ius Break brings together over 60 industry leaders, researchers, investors, and entrepreneurs from the global biotech sector. Packed with exciting talks, interactive panel discussions, and networking opportunities, this event provides a platform for discussing the latest trends and breakthrough innovations. Whether you’re an experienced professional or new to the field, this gathering is designed to keep you ahead in the fast-evolving world of biotechnology.
Event Overview
Date: February 6, 2025
Venue: Cambridge Tap, 32 St Andrew's St, Cambridge CB2 3AR, UK
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
Join us for a fantastic evening of networking! We look forward to seeing you in Cambridge, UK!
